{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:24:50Z","timestamp":1791645890978,"version":"4.3.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2019.02148","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T04:58:30Z","timestamp":1568782710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Safety of Infliximab for the Eye Under Human T-Cell Leukemia Virus Type 1 Infectious Conditions in vitro"],"prefix":"10.3389","volume":"10","author":[{"given":"Minami","family":"Uchida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koju","family":"Kamoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Karube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Ohno-Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ijc.2910370520","article-title":"Transformation of hamster spleen lymphocytes by human T-cell leukemia virus type I","volume":"37","author":"Akagi","year":"1986","journal-title":"Int. J. Cancer"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1182\/blood-2004-07-2850","article-title":"Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes","volume":"106","author":"Barnard","year":"2005","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1056\/NEJM200011303432201","article-title":"A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis","volume":"343","author":"Bathon","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/AID.2012.0132","article-title":"Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases","volume":"29","author":"Demontis","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/jop.2007.0104","article-title":"Adalimumab therapy for refractory uveitis: a pilot study","volume":"24","author":"Diaz-Llopis","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref6","first-page":"200","article-title":"Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells","volume":"66","author":"Elner","year":"1992","journal-title":"Lab. Investig."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12865-017-0191-2","article-title":"Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy","volume":"18","author":"Fukui","year":"2017","journal-title":"BMC Immunol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11910-017-0785-3","article-title":"Neurological complications of therapeutic monoclonal antibodies: trends from oncology to rheumatology","volume":"17","author":"Gill","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha","volume":"346","author":"Gorman","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref10","first-page":"2468","article-title":"Quantitative assay of human T-cell leukemia\/lymphoma virus transformation","volume":"47","author":"Graziano","year":"1987","journal-title":"Cancer Res."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1350-9462(00)00017-3","article-title":"Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes","volume":"20","author":"Holtkamp","year":"2001","journal-title":"Prog. Retin. Eye Res."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0161-6420(03)00406-8","article-title":"Infliximab in the treatment of refractory posterior uveitis","volume":"110","author":"Joseph","year":"2003","journal-title":"Ophthalmology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/ICU.0b013e328358b9ec","article-title":"HTLV infection and the eye","volume":"23","author":"Kamoi","year":"","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fmicb.2012.00270","article-title":"HTLV-1 uveitis","volume":"3","author":"Kamoi","year":"","journal-title":"Front. Microbiol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1006\/exer.1998.0517","article-title":"The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: a comparison with retinal pigment epithelial cells","volume":"67","author":"Kociok","year":"1998","journal-title":"Exp. Eye Res."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nmeth.2900","article-title":"Comparing samples\u2014part II","volume":"11","author":"Krzywinsk","year":"2014","journal-title":"Nat. Methods"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.coi.2005.04.008","article-title":"ICAM-1 co-stimulates target cells to facilitate antigen presentation","volume":"17","author":"Lebedeva","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e0117911","DOI":"10.1371\/journal.pone.0146210","article-title":"TNF-alpha mediates PKCdelta\/JNK1\/2\/c-Jun-dependent monocyte adhesion via ICAM-1 induction in human retinal pigment epithelial cells","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/ijms19103187","article-title":"Structural biology of the TNF\u03b1 antagonists used in the treatment of rheumatoid arthritis","volume":"19","author":"Lim","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1167\/iovs.05-1277","article-title":"HTLV-1 infection of human retinal pigment epithelial cells and inhibition of viral infection by an antibody to ICAM-1","volume":"47","author":"Liu","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1210\/jc.2005-0679","article-title":"Human T cell leukemia virus type I-infected patients with Hashimoto\u2019s thyroiditis and Graves\u2019 disease","volume":"90","author":"Matsuda","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/14740338.2016.1240783","article-title":"Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis","volume":"15","author":"Minozzi","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1349-7006.1992.tb00092.x","article-title":"HTLV-I uveitis: a distinct clinical entity caused by HTLV-I","volume":"83","author":"Mochizuki","year":"1992","journal-title":"Jpn. J. Cancer Res."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.preteyeres.2012.10.002","article-title":"Immunological homeostasis of the eye","volume":"33","author":"Mochizuki","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1128\/JCM.00781-09","article-title":"Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination","volume":"47","author":"Moens","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref500","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.3389\/fimmu.2018.02746","article-title":"Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon","volume":"9","author":"Mylonas","year":"2018","journal-title":"Front. Immunol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/s0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1080\/14740338.2017.1372421","article-title":"Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS registry)","volume":"16","author":"Perez-De-Lis","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1172\/JCI117735","article-title":"Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production","volume":"95","author":"Sagawa","year":"1995","journal-title":"J. Clin. Invest."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jmv.23181","article-title":"Current prevalence of HTLV-1 in Japan as determined by screening of blood donors","volume":"84","author":"Satake","year":"2012","journal-title":"J. Med. Virol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/carcin\/bgi274","article-title":"Functional inactivation of p53 by human T-cell leukemia virus type 1 tax protein: mechanisms and clinical implications","volume":"27","author":"Tabakin-Fix","year":"2006","journal-title":"Carcinogenesis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1076\/ocii.8.4.235.6454","article-title":"Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term follow-up","volume":"8","author":"Takahashi","year":"2000","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/jop.2016.0124","article-title":"Human T cell leukemia virus type 1 and eye diseases","volume":"33","author":"Terada","year":"","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e6021","DOI":"10.1097\/MD.0000000000006021","article-title":"Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: a case report","volume":"96","author":"Terada","year":"","journal-title":"Medicine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3109\/14397595.2013.844389","article-title":"Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series","volume":"25","author":"Umekita","year":"2015","journal-title":"Mod. Rheumatol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3892\/etm.2016.3548","article-title":"Risk of tuberculosis during infliximab therapy for inflammatory bowel disease, rheumatoid arthritis, and spondyloarthropathy: a meta-analysis","volume":"12","author":"Wang","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s12185-011-0934-4","article-title":"Current status of HTLV-1 infection","volume":"94","author":"Watanabe","year":"2011","journal-title":"Int. J. Hematol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/1744666X.2014.866038","article-title":"Paradoxical effects of anti-TNF-alpha agents in inflammatory diseases","volume":"10","author":"Wendling","year":"2014","journal-title":"Expert. Rev. Clin. Immunol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.02148\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T12:59:37Z","timestamp":1575723577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.02148\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":41,"alternative-id":["10.3389\/fmicb.2019.02148"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2019.02148","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"article-number":"2148"}}